Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial

Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial

Author Diehl, Alessandra Autor UNIFESP Google Scholar
Castro, Luiz Andre Autor UNIFESP Google Scholar
Faria, Roberta Autor UNIFESP Google Scholar
Laranjeira, Ronaldo Autor UNIFESP Google Scholar
Institution Universidade Federal de São Paulo (UNIFESP)
Abstract Objective: To evaluate anticraving action and tolerability of topiramate in cocaine user treatment. Method: Male users of inhaled cocaine which met criteria for cocaine dependence (Diagnostic and Statistical Manual of Mental Disorders, fourth edition) were selected for outpatient 12-week, open label trial with topiramate; individual dosage ranged between 25-300 mg/day. Main clinical variables were abstinence rate, craving intensity, frequency and duration, adherence, dropouts, side effects and impulsivity measure through Barratt Impulsivity Scale. Patients received assertive strategic counseling for abstinence assistance and medication monitoring evaluation every two weeks. Comparative analysis was made with intention to treat, missing values were replaced (last observation carried forward), and significance level was 5%. Results: Adherence to treatment was 57% (at least three evaluations), 32% dropped out (one evaluation). There were no severe side effects. Negative test average was 25.4% (31.2). Significant reduction in craving intensity and duration was observed in 25% of the sample. No statistical significant reduction in craving frequency was observed in 7.1%. Increase in frequency was observed in 10.7% and 82.1% did not present any variation. No significant statistical variations in Barratt Impulsivity Scale or in the total score were found in the final evaluation when compared to baseline. Conclusion: More randomized placebo-controlled trials with topiramate for cocaine dependants should be performed to evaluate preliminary evidence.
Keywords cocaine-related disorders
behavior, addictive
topiramate
clinical trial [publication type]
clinical protocols
Language English
Date 2008-06-01
Published in Revista Brasileira de Psiquiatria. São Paulo: Assoc Brasileira Psiquiatria, v. 30, n. 2, p. 132-135, 2008.
ISSN 1516-4446 (Sherpa/Romeo, impact factor)
Publisher Assoc Brasileira Psiquiatria
Extent 132-135
Origin http://dx.doi.org/10.1590/S1516-44462008005000012
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000256840100007
SciELO ID S1516-44462008005000012 (statistics in SciELO)
URI http://repositorio.unifesp.br/handle/11600/30682

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account